Among the few institutes selected AIIMS Delhi will begin the testing and clinical trial of Indian’s COVID-19 vaccine candidate Covaxin on today(July 20)

India is one of the latest vaccine producers in the world. With the COVID cases increasing day by day, the need for developing a vaccine for the same has become a major priority. India’s All India Institute of Medical Sciences (AIIMS) Ethics Committee gave its approval on Saturday to conduct the human clinical trial of the indigenously developed Covid-19 vaccine candidate Covaxin. The hospital started enrolling people who wish to volunteer for the vaccine’s testing process.

Phase I and II of the testing for Covaxin will be conducted in 12 selected institutes and AIIMS-Delhi is one among them. According to the reports in phase I, the vaccine would be tested on 375 volunteers and a maximum of 100 of them would be from AIIMS.

The Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV) has developed Covaxin, which is India’s first indigenous Covid-19 vaccine candidate. AIIMS Patna is the first institute where the trial for the testing began on Wednesday along with some other sites. About nine people have been tested there with a smaller dose.

Take a look:

People willing to participate in India’s first Covid-19 vaccine trial can send an SMS to or call on 7428847499

Also Read: Russia successfully completes the first-ever Coronavirus vaccine trial